TABLE 01. GLOBAL NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET, BY DRUG TYPE, 2017-2025 ($MILLION)
TABLE 02. NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET FOR VITAMIN E & PIOGLITAZONE, BY REGION, 2017-2025 ($MILLION)
TABLE 03. NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET FOR OBETICHOLIC ACID, BY REGION, 2017-2025 ($MILLION)
TABLE 04. NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET FOR ELAFIBRANOR, BY REGION, 2017-2025 ($MILLION)
TABLE 05. NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET FOR SELONSERTIB & CENICRIVIROC, BY REGION, 2017-2025 ($MILLION)
TABLE 06. GLOBAL NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 07. PHARMACY NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET FOR HOSPITAL, BY REGION, 2017-2025 ($MILLION)
TABLE 08. NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET FOR ONLINE PROVIDERS, BY REGION, 2017-2025 ($MILLION)
TABLE 09. NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET FOR RETAIL PHARMACY, BY REGION, 2017-2025 ($MILLION)
TABLE 10. NONALCOHOLIC STEATOHEPATITIS (NASH) REVENUE, BY REGION, 2017-2025 ($MILLION)
TABLE 11. NORTH AMERICA NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 12. NORTH AMERICA NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET, BY DRUG TYPE, 2017-2025 ($MILLION)
TABLE 13. NORTH AMERICA NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 14. EUROPE NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 15. EUROPE NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET, BY DRUG TYPE, 2017-2025 ($MILLION)
TABLE 16. EUROPE NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 17. ASIA-PACIFIC NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 18. ASIA-PACIFIC NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET, BY DRUG TYPE, 2017-2025 ($MILLION)
TABLE 19. ASIA-PACIFIC NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 20. LAMEA NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 21. LAMEA NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET, BY DRUG TYPE, 2017-2025 ($MILLION)
TABLE 22. LAMEA NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET, BY SALES CHANNEL, 2017-2025 ($MILLION)
TABLE 23. ALLERGAN: COMPANY SNAPSHOT
TABLE 24. ALLERGAN: OPERATING SEGMENTS
TABLE 25. ALLERGAN: PRODUCT PORTFOLIO
TABLE 26. ZYDUS CADILA: COMPANY SNAPSHOT
TABLE 27. ZYDUS CADILA: PRODUCT PORTFOLIO
TABLE 28. CONATUS: COMPANY SNAPSHOT
TABLE 29. CONATUS: PRODUCT PORTFOLIO
TABLE 30. GALMED: COMPANY SNAPSHOT
TABLE 31. GALMED: PRODUCT PORTFOLIO
TABLE 32. GEMPHIRE: COMPANY SNAPSHOT
TABLE 33. GEMPHIRE: PRODUCT PORTFOLIO
TABLE 34. GENFIT: COMPANY SNAPSHOT
TABLE 35. GENFIT: PRODUCT PORTFOLIO
TABLE 36. GILEAD: COMPANY SNAPSHOT
TABLE 37. GILEAD: PRODUCT PORTFOLIO
TABLE 38. INTERCEPT: COMPANY SNAPSHOT
TABLE 39. INTERCEPT: PRODUCT PORTFOLIO
TABLE 40. NOVARTIS AG: COMPANY SNAPSHOT
TABLE 41. NOVARTIS: OPERATING SEGMENTS
TABLE 42. NOVARTIS AG: PRODUCT PORTFOLIO
TABLE 43. SHIRE: COMPANY SNAPSHOT
TABLE 44. SHIRE: PRODUCT PORTFOLIO

LIST OF FIGURE

FIGURE 01. NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP PLAYER POSITIONING
FIGURE 04. TOP WINNING STRATEGIES, BY YEAR, 20142018*
FIGURE 05. TOP WINNING STRATEGIES, BY DEVELOPMENT, 20142018* (%)
FIGURE 06. TOP WINNING STRATEGIES, BY COMPANY, 20142018*
FIGURE 07. IMPACT ANALYSES
FIGURE 08. NONALCOHOLIC STEATOHEPATITIS (NASH) PIPELINE (POTENTIAL PHASE II AND III DRUGS)
FIGURE 09. U.S. NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET, 2017-2025 ($MILLION)
FIGURE 10. CANADA NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET, 2017-2025 ($MILLION)
FIGURE 11. MEXICO NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET, 2017-2025 ($MILLION)
FIGURE 12. GERMANY NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET, 2017-2025 ($MILLION)
FIGURE 13. FRANCE NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET, 2017-2025 ($MILLION)
FIGURE 14. UK NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET, 2017-2025 ($MILLION)
FIGURE 15. ITALY NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET, 2017-2025 ($MILLION)
FIGURE 16. SPAIN NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET, 2017-2025 ($MILLION)
FIGURE 17. REST OF EUROPE NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET, 2017-2025 ($MILLION)
FIGURE 18. JAPAN NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET, 2017-2025 ($MILLION)
FIGURE 19. CHINA NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET, 2017-2025 ($MILLION)
FIGURE 20. AUSTRALIA NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET, 2017-2025 ($MILLION)
FIGURE 21. INDIA NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET, 2017-2025 ($MILLION)
FIGURE 22. SOUTH KOREA NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET, 2017-2025 ($MILLION)
FIGURE 23. REST OF ASIA-PACIFIC NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET, 2017-2025 ($MILLION)
FIGURE 24. BRAZIL NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET, 2017-2025 ($MILLION)
FIGURE 25. SAUDI ARABIA NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET, 2017-2025 ($MILLION)
FIGURE 26. SOUTH AFRICA NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET, 2017-2025 ($MILLION)
FIGURE 27. REST OF LAMEA NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET, 2017-2025 ($MILLION)
FIGURE 28. ALLERGAN: NET SALES, 2015-2017 ($MILLION)
FIGURE 29. ALLERGAN: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 30. ZYDUS CADILA: NET SALES, 2015-2017 ($MILLION)
FIGURE 31. ZYDUS CADILA: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 32. CONATUS: NET SALES, 20162017 ($MILLION)
FIGURE 33. GALMED: NET SALES, 20162017 ($MILLION)
FIGURE 34. GENFIT: NET SALES, 2015-2017 ($MILLION)
FIGURE 35. GILEAD: NET SALES, 2015-2017 ($MILLION)
FIGURE 36. GILEAD: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 37. INTERCEPT: NET SALES, 2015-2017 ($MILLION)
FIGURE 38. NOVARTIS: NET SALES, 2015-2017 ($MILLION)
FIGURE 39. NOVARTIS: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 40. NOVARTIS: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 41. SHIRE: NET SALES, 2015-2017 ($MILLION)
FIGURE 42. SHIRE: REVENUE SHARE BY PRODUCT, 2017 (%)
FIGURE 43. SHIRE: REVENUE SHARE BY GEOGRAPHY, 2017 (%)